Williet, N., & Roblin, X. (2016). Trend towards dose reduction of azathioprine as monotherapy in inflammatory bowel disease patients: What about for combination therapy? Therap Adv Gastroenterol.
Chicago Stili AlıntıWilliet, Nicolas, ve Xavier Roblin. "Trend Towards Dose Reduction of Azathioprine As Monotherapy in Inflammatory Bowel Disease Patients: What About for Combination Therapy?" Therap Adv Gastroenterol 2016.
MLA AlıntıWilliet, Nicolas, ve Xavier Roblin. "Trend Towards Dose Reduction of Azathioprine As Monotherapy in Inflammatory Bowel Disease Patients: What About for Combination Therapy?" Therap Adv Gastroenterol 2016.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..